OptimizeRx (NASDAQ: OPRX), a provider of healthcare technology solutions for life sciences companies, announced that it has entered into a $35 million senior secured credit facility with Fifth Third Bank. The facility includes a $25 million term loan and a $10 million revolving credit facility, which was undrawn at closing. Roth Capital Partners served as financial advisor on the transaction. The full announcement is available at https://ibn.fm/G0Fj3.
The new credit facility provides OptimizeRx with additional financial flexibility to support its strategic initiatives. The company plans to use the proceeds for general corporate purposes, including working capital and potential growth opportunities. This funding comes at a time when OptimizeRx is expanding its platform capabilities, particularly through its artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT). These tools enable life sciences brands to deliver timely, relevant, and hyper-local engagement with healthcare providers (HCPs) and patients.
OptimizeRx specializes in bridging the gap between HCP and direct-to-consumer (DTC) strategies, creating synchronized marketing solutions that drive faster treatment decisions and improved patient outcomes. The company’s commitment to privacy-safe, patient-centric technology ensures that each interaction is designed to make a meaningful impact. By partnering with some of the world’s leading pharmaceutical and life sciences companies, OptimizeRx aims to transform the healthcare landscape.
Headquartered in Waltham, Massachusetts, OptimizeRx continues to innovate in the healthcare technology space. The secured credit facility with Fifth Third Bank underscores the confidence in the company’s business model and growth trajectory. For more information about OptimizeRx, visit www.optimizerx.com.
